Table of Contents
ISRN Gastroenterology
Volume 2011, Article ID 708215, 3 pages
http://dx.doi.org/10.5402/2011/708215
Clinical Study

The Clinical Features and Prognosis of Gastric Remnant Carcinoma after Treatment

Department of Internal Medicine, College of Medicine, China Medical University Hospital and China Medical University, No. 2 Yu-Der Road, Taichung 40421, Taiwan

Received 11 July 2011; Accepted 7 September 2011

Academic Editor: A. Weimann

Copyright © 2011 Ken-Sheng Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Introduction. The incidence of gastric remnant carcinoma does not decrease after partial gastrectomy. The aim of this study was to evaluate the clinical features and prognosis of gastric remnant carcinoma after treatment. Methods. Among 412 gastric carcinoma patients who were admitted to our hospital, 21 were found to have gastric remnant carcinoma. We analyzed their clinicopathological features and prognosis. Results. Prognosis did not differ significantly in terms of gender, age, tumor lymph node metastasis stage, tumor location, and time interval between first and subsequent operations. However, it was influenced by intensive curative gastrectomy with resection of local lymph nodes. Conclusion. Long-term follow-up after gastrectomy, appropriate curative resection, and prevention and management of comorbidities are important to detect gastric remnant carcinoma at an early stage.